Ultragenyx Pharmaceutical Inc. Insider Trading for October 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for October 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 30 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 54.50 | 97 | 5,287 | 34,903 | |
Oct 30 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 100.00 | 97 | 9,700 | 23,968 | 24.1 K to 24 K (-0.40 %) |
Oct 30 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 54.50 | 97 | 5,287 | 24,065 | 24 K to 24.1 K (+0.40 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 92.69 | 852 | 78,972 | 610,189 | 611 K to 610.2 K (-0.14 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 88.00 | 262 | 23,056 | 35,789 | 36.1 K to 35.8 K (-0.73 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 88.00 | 325 | 28,600 | 23,968 | 24.3 K to 24 K (-1.34 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Sell | S | 87.98 | 262 | 23,051 | 101,478 | 101.7 K to 101.5 K (-0.26 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Harris Erik | EVP & Chief Commerc ... | Sell | S | 88.00 | 220 | 19,360 | 23,370 | 23.6 K to 23.4 K (-0.93 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Sell | S | 88.00 | 262 | 23,056 | 46,299 | 46.6 K to 46.3 K (-0.56 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Sell | S | 88.00 | 262 | 23,056 | 34,699 | 35 K to 34.7 K (-0.75 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Sell | S | 87.98 | 146 | 12,845 | 16,436 | 16.6 K to 16.4 K (-0.88 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | EVP, Finance | Sell | S | 87.99 | 375 | 32,996 | 97,812 | 98.2 K to 97.8 K (-0.38 %) |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Sell | S | 94.47 | 2,780 | 262,627 | 46,561 | 49.3 K to 46.6 K (-5.63 %) |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 54.50 | 10,000 | 545,000 | 35,000 | |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 95.00 | 10,000 | 950,000 | 24,293 | 34.3 K to 24.3 K (-29.16 %) |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 54.50 | 10,000 | 545,000 | 34,293 | 24.3 K to 34.3 K (+41.16 %) |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Option Exercise | A | 95.50 | 40,000 | 3,820,000 | 40,000 | |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Dier Mardi | CFO & Executive Vic ... | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Oct 07 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 48.43 | 10,000 | 484,300 | 17,000 | |
Oct 07 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 90.00 | 10,000 | 900,000 | 24,293 | 34.3 K to 24.3 K (-29.16 %) |
Oct 07 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 48.43 | 10,000 | 484,300 | 34,293 | 24.3 K to 34.3 K (+41.16 %) |